TY - JOUR
T1 - Cognitive training in Parkinson's Disease
T2 - a theoretical perspective
AU - Walton, Courtney C.
AU - Naismith, Sharon L
AU - Lampit, Amit
AU - Mowszowski, Loren
AU - Lewis, Simon J. G.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Cognitive impairment is now widely accepted as a fundamental aspect of Parkinson's disease (PD). Given the prevalence of cognitive impairment and the associated impact on well-being, evidence-based interventions are needed. However, while research is continually accumulating in order to better understand the pathology and trajectory of cognitive changes, treatment options lag behind. Nonpharmacological approaches are of particular interest in this group, given the typical polypharmacy already present in PD patients. In this regard, cognitive training (CT) is a relatively new and prominent therapeutic option with accumulating scientific support and increasing public awareness. Research has now established benefits across many different populations, and trials investigating the use of CT specifically in PD are becoming more common. We offer a brief summary of CT and its efficacy in PD samples to date, as well as discuss areas requiring further exploration in this group. Crucially, we suggest that CT should be supported as a research priority in PD, given both proven and potential benefits as a noninvasive and well-tolerated behavioral intervention for cognitive impairment.
AB - Cognitive impairment is now widely accepted as a fundamental aspect of Parkinson's disease (PD). Given the prevalence of cognitive impairment and the associated impact on well-being, evidence-based interventions are needed. However, while research is continually accumulating in order to better understand the pathology and trajectory of cognitive changes, treatment options lag behind. Nonpharmacological approaches are of particular interest in this group, given the typical polypharmacy already present in PD patients. In this regard, cognitive training (CT) is a relatively new and prominent therapeutic option with accumulating scientific support and increasing public awareness. Research has now established benefits across many different populations, and trials investigating the use of CT specifically in PD are becoming more common. We offer a brief summary of CT and its efficacy in PD samples to date, as well as discuss areas requiring further exploration in this group. Crucially, we suggest that CT should be supported as a research priority in PD, given both proven and potential benefits as a noninvasive and well-tolerated behavioral intervention for cognitive impairment.
KW - Parkinson’s disease
KW - dementia
KW - cognitive impairment
KW - cognitive training
KW - cognitive rehabilitation
UR - http://purl.org/au-research/grants/nhmrc/1008117
UR - http://www.scopus.com/inward/record.url?scp=85012926764&partnerID=8YFLogxK
U2 - 10.1177/1545968316680489
DO - 10.1177/1545968316680489
M3 - Article
C2 - 27899737
SN - 1545-9683
VL - 31
SP - 207
EP - 216
JO - Neurorehabilitation and Neural Repair
JF - Neurorehabilitation and Neural Repair
IS - 3
ER -